Apatinib, a Novel Tyrosine Kinase Inhibitor, Promotes ROS-Dependent Apoptosis and Autophagy via the Nrf2/HO-1 Pathway in Ovarian Cancer Cells

Oxidative Medicine and Cellular Longevity
Xiaodan SunQingchang Li

Abstract

Apatinib, a new-generation oral tyrosine kinase inhibitor targeting the vascular endothelial growth factor receptor 2 (VEGFR2) signaling pathway, shows favorable therapeutic effects in various malignant tumors. However, its effect on ovarian cancer has not yet been characterized. Here, we demonstrated that apatinib inhibited ovarian cancer cell growth and migration in a concentration-dependent manner. Further, we found that apatinib could directly act on tumor cells and promote ROS-dependent apoptosis and autophagy. Mechanistically, we showed that apatinib suppressed glutathione to generate ROS via the downregulation of the nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase 1 (HO-1) pathway and maintained an antitumor effect at a low level of VEGFR2 in ovarian cancer, suggesting that combination of apatinib with Nrf2 inhibitor may be a promising therapy strategy for patients with ovarian cancer.

References

Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert F OzolsUNKNOWN Gynecologic Oncology Group
Jul 17, 2004·Free Radical Biology & Medicine·Truyen NguyenCecil B Pickett
Jul 8, 2008·Molecular Aspects of Medicine·Shelly C Lu
Sep 16, 2009·Free Radical Biology & Medicine·Gi-seong ShimMi-Kyoung Kwak
Jul 8, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Neil R SmithChris Womack
Aug 24, 2010·Trends in Biochemical Sciences·Ruth Scherz-Shouval, Zvulun Elazar
Feb 18, 2011·Future Oncology·Ursula A Matulonis
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Sep 22, 2012·Biochimica Et Biophysica Acta·Shelly C Lu
Oct 25, 2014·Nature Reviews. Cancer·Simran S Sabharwal, Paul T Schumacker
Jan 16, 2015·Redox Biology·Laura Poillet-PerezMichaël Boyer-Guittaut
Feb 28, 2015·Cellular and Molecular Neurobiology·Lulu LiQiang Zhang
May 23, 2015·Expert Opinion on Emerging Drugs·Amanda L JacksonThomas J Herzog
Dec 24, 2015·Oxidative Medicine and Cellular Longevity·A L FurfaroM Nitti
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Aug 17, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lorenzo FornaroAlfredo Falcone
Nov 5, 2016·Biochimica Et Biophysica Acta·Maureen Redza-Dutordoir, Diana A Averill-Bates
Nov 1, 2017·Iranian Journal of Basic Medical Sciences·Wu LuYu Honggang
Dec 1, 2017·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Zhijian JinWeihua Qiu
Dec 19, 2017·Gynecologic Oncology·Mingming MiaoJie Tang
Feb 8, 2018·Oxidative Medicine and Cellular Longevity·Ibrahim H KankiaYusuf Y Deeni
Jun 1, 2018·Oncotarget·Feng LiJilong Yang
Jun 20, 2018·The Journal of Cell Biology·Ankita Bansal, M Celeste Simon
Jun 29, 2018·International Journal of Molecular Sciences·Sofia C Nunes, Jacinta Serpa
Jul 28, 2018·OncoTargets and Therapy·Deze ZhaoXiaochun Zhang
Jan 18, 2019·Gynecologic Oncology·Jing DingFan-Ling Meng

❮ Previous
Next ❯

Citations

Jul 28, 2021·Pharmacological Reviews·Trevor M PenningTea Lanišnik Rižner
Aug 7, 2021·Cellular Signalling·Chorlada PaiboonrungruangXiaoxin Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection
Assay
PCR

Software Mentioned

GraphPad Prism
ImageJ

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms